Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
38 studies found for:    Open Studies | "Keratosis, Actinic"
Show Display Options
Rank Status Study
1 Not yet recruiting IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
Condition: Keratosis, Actinic
Interventions: Drug: Imiquimod;   Drug: 5-fluorouracil;   Drug: Ingenol mebutate;   Procedure: methylaminolevulinate photodynamic therapy
2 Recruiting Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Procedure: Aminolevulinic acid based photodynamic therapy
3 Recruiting Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
Condition: Actinic Keratosis
Interventions: Drug: SR-T100  gel;   Drug: Vehicle gel
4 Recruiting Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses
Condition: Keratosis, Actinic
Interventions: Drug: 5-fluorouracil/salicylic acid;   Drug: Vehicle
5 Recruiting Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: SR-T100 gel
6 Not yet recruiting Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Procedure: Topical retinoid and blue-light therapy with photosensitizing agent;   Procedure: Photodynamic Therapy (PDT)
7 Unknown  Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
Condition: Actinic Keratoses
Interventions: Other: photodynamic therapy;   Drug: imiquimod 5% cream
8 Recruiting Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 2%HAL With 16%MAL
Condition: Actinic Keratoses
Interventions: Drug: Hexylaminolaevulinate cream;   Drug: Methylaminolaevulinate cream
9 Recruiting Efficacy and Safety Phase II Dose-ranging Study of SR-T100 to Treat Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Vehicle gel;   Drug: SR-T100 with 1.0% of SM;   Drug: SR-T100 with 2.3% of SM
10 Recruiting Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
Condition: Actinic Keratosis
Intervention: Drug: Ingenol Mebutate
11 Recruiting Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + ALA Photodynamic Therapy
Condition: Actinic Keratosis
Interventions: Drug: Aminolevulinic Acid;   Drug: Topical Solution Vehicle;   Device: BLU-U;   Procedure: Cryotherapy
12 Recruiting Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
Condition: Actinic Keratosis
Interventions: Drug: Aminolevulinic Acid (ALA);   Drug: Topical Solution Vehicle;   Device: BLU-U Blue Light Photodynamic Therapy Illuminator
13 Unknown  Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
14 Recruiting Study of A-101 for the Treatment of Seborrheic Keratosis
Condition: Seborrheic Keratosis
Intervention: Drug: A-101
15 Recruiting Treating Actinic Keratoses With Natural Daylight PDT: Comparing Two Light Sensitizers (ALA and MAL)
Condition: Actinic Keratoses (gr I-III)
Interventions: Drug: ALA sensitizer;   Drug: MAL sensitizer
16 Recruiting Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo
17 Recruiting Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Drug: Ingenol Mebutate;   Procedure: Cryotherapy
18 Recruiting Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate
19 Recruiting Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Procedure: Pretreatment with CO2 laser before photodynamic therapy;   Device: Only photodynamic therapy
20 Recruiting Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Indicates status has not been verified in more than two years